We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ono and Galapagos Subsidiary BioFocus Sign Target Discovery Agreement in the Field of Autoimmune Disease

News   Jan 11, 2011

 
Ono and Galapagos Subsidiary BioFocus Sign Target Discovery Agreement  in the Field of Autoimmune Disease
 
 
 

RELATED ARTICLES

Non-invasive Diagnostic Approach to Inflammatory Bowel Disease

News

Finding a noninvasive diagnostic method for inflammatory bowel disease would remove the reliance on endoscopy, which is invasive and does not provide information on specific mediators.

READ MORE

Immune System Can Slow Degenerative Eye Disease

News

Contrary to previous work, a new study shows that the complement system, part of the innate immune system, plays a protective role to slow retinal degeneration in a mouse model of retinitis pigmentosa, an inherited eye disease.

READ MORE

Chemists’ Success in Synthesis Drives Development of Anti-cancer Agent

News

Researchers have now synthesized sufficient quantities of E7130, a drug candidate from the halichondrin class, to enable for the first time rigorous studies of its biological activity, pharmacological properties, and efficacy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE